Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cecchin

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of the American Society of Nephrology : JASN|July 1, 1997
Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patientsS De Marchi, E Cecchin, E Falleti, et al.
Journal of the American Society of Nephrology : JASN|August 1, 1996
Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patientsS De Marchi, E Falleti, R Giacomello, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Atypical antiglomerular basement membrane disease associated with defective leukocyte phagocytosis and hyper-IgE syndromeS De Marchi, E Cecchin, M Pirisi, et al.
American Journal of Nephrology|January 1, 1984
Close genetic linkage between HLA and renal glycosuriaS De Marchi, E Cecchin, A Basile, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Is renal glycosuria a benign condition?S De Marchi, E Cecchin, A Basile, et al.
ESMO Open|March 29, 2023
Implementation of dihydropyrimidine dehydrogenase deficiency testing in EuropeM de With, A Sadlon, E Cecchin, et al.
The Pharmacogenomics Journal|March 18, 2015
A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patientsS Chen, I Laverdiere, A Tourancheau, et al.
The Pharmacogenomics Journal|April 7, 2010
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapyE Cecchin, M Agostini, S Pucciarelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 15, 2017
SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorderM Toffoli, E Dreussi, E Cecchin, et al.
The Pharmacogenomics Journal|October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatinE Cecchin, G Perrone, S Nobili, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of the American Society of Nephrology : JASN|July 1, 1997
Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patientsS De Marchi, E Cecchin, E Falleti, et al.
Journal of the American Society of Nephrology : JASN|August 1, 1996
Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patientsS De Marchi, E Falleti, R Giacomello, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Atypical antiglomerular basement membrane disease associated with defective leukocyte phagocytosis and hyper-IgE syndromeS De Marchi, E Cecchin, M Pirisi, et al.
American Journal of Nephrology|January 1, 1984
Close genetic linkage between HLA and renal glycosuriaS De Marchi, E Cecchin, A Basile, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Is renal glycosuria a benign condition?S De Marchi, E Cecchin, A Basile, et al.
ESMO Open|March 29, 2023
Implementation of dihydropyrimidine dehydrogenase deficiency testing in EuropeM de With, A Sadlon, E Cecchin, et al.
The Pharmacogenomics Journal|March 18, 2015
A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patientsS Chen, I Laverdiere, A Tourancheau, et al.
The Pharmacogenomics Journal|April 7, 2010
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapyE Cecchin, M Agostini, S Pucciarelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 15, 2017
SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorderM Toffoli, E Dreussi, E Cecchin, et al.
The Pharmacogenomics Journal|October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatinE Cecchin, G Perrone, S Nobili, et al.
Pageof 9